Multi-Million Dollar Cannabis Campus Sale To Help Canadian Pot Producer Pursue Organic Growth

Zinger Key Points
  • Cronos entered into an agreement with Future Farmco for the sale and leaseback of its Ontario property.
  • CEO says sale will help improve the gross margin profile of the company and lower costs.

Cronos Group Inc. CRON CRON announced on Monday that its wholly-owned subsidiary entered into an agreement with Future Farmco Canada Inc., a vertical farming company, for the sale and leaseback of its Ontario, Cananda-based property.

What Happened

Under the deal, Future Farmco agreed to acquire Peace Naturals Campus at 4491 Concession 12 Sunnidale Road for CA$23 million ($16.9 million in cash).

The parties also plan to enter into a lease agreement upon closing for portions of the Peace Naturals Campus, ensuring continued operations.

That deal will include a five-year term and one five-year renewal option that may be exercised by Cronos.

Cronos will also have an option to lease certain additional space during the term of the lease.

Why It Matters

Mike Gorenstein, chairman, president and CEO of the Toronto-based company said the deal is part of Cronos’ efforts to reduce costs.

“More specifically, this sale will aid in improving the gross margin profile of our business, while lowering costs and increasing our agility,” Gorenstein said. “This sale only strengthens our industry-leading balance sheet and allows us to continue to pursue organic growth and future transactions that bolster Cronos’ existing value. We do not expect any interruption to our current operations and plan to carry out existing growth plans within our leased space at the facility.”

What’s Next

Closing of the transaction with Future Farmco is subject to certain conditions outlined in Cronos’ Form 8-K.

Within 180 days of the sale agreement date, Future Farmco must confirm in writing that it is satisfied with various aspects of the property and has secured financing for the transaction. Cronos must receive approval from Health Canada for site perimeter changes.

CRON Price Action

Cronos’ shares traded 0.98% lower at $2.03 per share during the pre-market session on Monday morning.

Missed the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
 Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
 Just this year, the PotProfits portfolio has seen smoking-hot gains like:
  •  47.10% with $GTBIF
  •  40.23% with $TCNNF
  •  21.50% with $VFF
 But here’s the kicker: Michael is about to release his next potential winners, and he’s chomping at the bit to share these ticker symbols with you ASAP.Don’t miss out on the green rush!

Related News

Photo: Courtesy of Iryna Rahalskaya on Shutterstock

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisGovernmentNewsPenny StocksRegulationsPoliticsAsset SalesSmall CapMarketsGeneralCanada Cannabiscannabis campusmarijuana saleMike Gorenstein
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.